Cambrex Corp
NYSE:CBM
$6.84
-$0.16
(-2.29%)
Quote as of 3:45 PM EST on 02/09/12
Cambrex Corp. (CBM) Misses Q4 EPS by 2c, Offers Weak FY12 Sales Guidance
Cambrex sees 2012 capex $15M-$18M
Cambrex sees 2012 EBITDA $47M-$53M vs. $46.9M in 2011
Cambrex reports Q4 cont ops EPS 10c vs. consensus 12c
Cambrex Reports Fourth Quarter and Full Year 2011 Results
Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
5 Awesome Stocks That Could Double in 2012
Cambrex sees FY11 revenue up 5%-7% vs. consensus $250.25M
Cambrex reports Q3 EPS 10c vs. consensus 7c
Cambrex Reports Third Quarter 2011 Results
Cambrex to Announce Third Quarter 2011 Financial Results on November 3, 2011
Cambrex to Announce Third Quarter 2011 Financial Results on November 3, 2011
Cambrex to Announce Third Quarter 2011 Financial Results on November 3, 2011
Cambrex Corp and Hi-Tech Pharmacal Co., Inc. - Zacks #1 Rank Top Performers
Cambrex shares soar as 2Q results top estimates
Cambrex sees FY11 CapEx $14M-$17M
Cambrex sees FY11 to increase 3%-7% from FY10 vs. consensus $238.85M
Cambrex reports Q2 EPS 16c vs. consensus 13c
Cambrex Reports Second Quarter of 2011 Results
Cambrex Corp. (CBM) Tops Q2 EPS by 3c
Cambrex Reports Second Quarter of 2011 Results
Cambrex to Announce Second Quarter 2011 Financial Results on August 2, 2011
Cambrex to Announce Second Quarter 2011 Financial Results on August 2, 2011
Tillotts gains access to Cambrex' 5-ASA-based technology in IBD
Cambrex, Tillotts enter development/commercialization agreement
Cambrex Corp. Reports Operating Results (10-Q)
Cambrex reports Q1 EPS 9c vs. consensus 8c
Cambrex Corporation. (CBM) Tops Q1 EPS by 2c
Cambrex to Announce First Quarter 2011 Financial Results on May 5, 2011
12 Small-Cap Biotech Stocks Being Snapped Up by Mutual Fund Investors
